Citius Pharmaceuticals, Inc. (CTXR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.3M | -13.01M | -11.88M | -5.41M | -4.54M | -4.73M | -5.91M | -8.37M | -7.79M | -6.14M | -6.8M | -9.58M |
| Operating CF Margin % | -77.97% | -329.83% | - | - | - | - | -3791.98% | - | - | - | - | - |
| Operating CF Growth % | 71.36% | -175.27% | -100.94% | 35.38% | 41.7% | 22.97% | 13.05% | 12.68% | 0.85% | -27.17% | -7.39% | -24.25% |
| Net Income | -21.23M | -8.22M | -8.74M | -9.2M | -11.51M | -10.28M | -11.08M | -10.57M | -8.54M | -9.23M | -9.94M | -8.48M |
| Depreciation & Amortization | 1.76M | 556.96K | 62.04K | 41.37K | 56.01K | 54.84K | 53.69K | 52.85K | 52.07K | 51.01K | 49.97K | 49.02K |
| Stock-Based Compensation | 0 | 4.28M | 2.89M | 2.72M | 2.7M | 2.52M | 2.64M | 3.06M | 3.18M | 3.06M | 3.08M | 1.17M |
| Deferred Taxes | -231.21K | 0 | 264.24K | 264.24K | 264.24K | 264.24K | 144K | 144K | 144K | 144K | 144K | 144K |
| Other Non-Cash Items | -3.09M | -3.41M | 26.6K | 0 | 0 | 0 | 0 | 109.95K | 0 | 76.15K | 3.33M | 918.07K |
| Working Capital Changes | 21.49M | -6.22M | -6.38M | 771.97K | 3.95M | 2.71M | 2.33M | -1.16M | -2.61M | -233.46K | -126.19K | -2.47M |
| Change in Receivables | 2.97M | -4.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -20.25K | -352.65K | -3.71M | -1.87M | -957.88K | -6.11M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.57M | 0 | 3.6M | 725.81K | 2M | 2.44M | 3.26M | -1.01M | 22.26K | -280.08K | -152.33K | 354.07K |
| Cash from Investing | -600K | -4.4M | -5.75M | 0 | 0 | 0 | -5M | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -600K | 0 | -5.75M | 0 | 0 | 0 | -5M | -4 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 35.99% | - | - | - | - | - | 3206.65% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -4.4M | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Cash from Financing | -1.23M | 20.88M | 15.79M | 11.47M | 3.47M | 2.57M | -3.75M | 13.72M | 0 | 0 | -687 | 13.8M |
| Debt Issued (Net) | -1M | 0 | -1M | 1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -231.2K | 0 | 15.79M | 10.47M | 3.47M | 2.57M | 84.73K | 13.72M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 20.88M | 1M | 0 | 0 | 0 | -3.83M | 0 | 0 | 0 | -687 | 13.8M |
| Net Change in Cash | -3.13M | 3.47M | -1.84M | 6.06M | -1.07M | -2.15M | -14.66M | 5.35M | -7.79M | -6.14M | -6.8M | 4.22M |
| Free Cash Flow | -1.3M | -13.01M | -11.88M | -5.41M | -4.54M | -4.73M | -5.91M | -8.37M | -7.79M | -6.14M | -6.8M | -9.58M |
| FCF Margin % | -77.97% | -329.83% | - | - | - | - | -3791.98% | - | - | - | - | - |
| FCF Growth % | 71.36% | -175.27% | -100.94% | 35.38% | 41.7% | 22.97% | 13.05% | 12.68% | 0.85% | -27.17% | -7.39% | -24.25% |
| FCF per Share | -0.06 | -0.61 | -0.66 | -0.49 | -0.39 | -0.41 | -0.51 | -0.72 | -0.73 | -0.58 | -0.64 | -0.93 |
| FCF Conversion (FCF/Net Income) | 0.06x | 1.58x | 1.49x | 0.62x | 0.42x | 0.48x | 0.55x | 0.79x | 0.91x | 0.66x | 0.68x | 1.13x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |